Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 19603148)

Published in Clin Rev Allergy Immunol on April 01, 2010

Authors

Merav Lidar1, Amir Dori, Yair Levy, Zvi Lidar, Joab Chapman, Pnina Langevitz

Author Affiliations

1: Rheumatology Unit, Sheba Medical Center (SMC), Tel Hashomer Hospital, Ramat Gan, Israel. merav.lidar@sheba.health.gov.il

Articles by these authors

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum (2002) 3.96

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum (2004) 1.89

Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol (2005) 1.56

Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med (2007) 1.55

Surgical management of metastatic bone disease. J Bone Joint Surg Am (2009) 1.55

Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol (2012) 1.53

A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model. J Urol (2009) 1.50

Comparison of pediatric appendectomy outcomes between pediatric surgeons and general surgery residents. J Surg Res (2012) 1.48

Familial Mediterranean fever in Ashkenazi Jews: the mild end of the clinical spectrum. J Rheumatol (2009) 1.45

Soluble transferrin receptor as a diagnostic laboratory test for detection of iron deficiency anemia in acute illness of hospitalized patients. Isr Med Assoc J (2011) 1.45

Aquaporin 4 molecular mimicry and implications for neuromyelitis optica. J Neuroimmunol (2013) 1.42

Antiphospholipid syndrome following a diphtheria-tetanus vaccination: coincidence vs. causality. Isr Med Assoc J (2010) 1.41

Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel. Isr Med Assoc J (2005) 1.41

Dabigatran etexilate linked to fatal gastrointestinal hemorrhage. Isr Med Assoc J (2014) 1.41

Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr Med Assoc J (2004) 1.39

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J Rheumatol (2007) 1.38

Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res (2005) 1.35

Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum (2005) 1.34

Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol (2011) 1.28

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum (2007) 1.27

Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products. J Biol Chem (2004) 1.20

Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum (2007) 1.19

The infectious etiology of vasculitis. Autoimmunity (2009) 1.16

Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci (2008) 1.15

White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Magn Reson Imaging (2005) 1.09

An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08

Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol (2012) 1.08

Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis Rheum (2004) 1.05

Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (2002) 1.03

Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol (2003) 1.03

Hearing loss as the presenting feature of systemic vasculitis. Ann N Y Acad Sci (2007) 1.01

Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med (2015) 1.00

Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum (2004) 0.98

The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J (2009) 0.97

TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells. Immunobiology (2009) 0.97

Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol (2010) 0.96

Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J Comp Neurol (2002) 0.96

Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol (2004) 0.96

Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J (2003) 0.95

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Arthritis Res Ther (2006) 0.95

Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis. Brain Struct Funct (2012) 0.95

Web-based multi-center data management system for clinical neuroscience research. J Med Syst (2010) 0.94

Crohn disease in patients with familial Mediterranean fever. Medicine (Baltimore) (2002) 0.94

Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. Neurobiol Dis (2003) 0.93

Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci (2007) 0.93

Incomplete response to colchicine in M694V homozygote FMF patients. Autoimmun Rev (2012) 0.93

Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain (2009) 0.93

Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth? Ann N Y Acad Sci (2009) 0.92

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.92

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice. BMC Med (2013) 0.92

Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann N Y Acad Sci (2005) 0.90

Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology (2009) 0.90

Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci (2009) 0.90

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.90

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PLoS One (2013) 0.89

The sense of smell in systemic lupus erythematosus. Arthritis Rheum (2009) 0.89

Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci (2009) 0.89

The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod (2003) 0.89

A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome--a case series. Ann N Y Acad Sci (2007) 0.89

Chronic idiopathic granulomatous mastitis. Ann N Y Acad Sci (2007) 0.88

Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol (2005) 0.88

MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease. Cerebellum (2009) 0.88

Changes in axonal morphology in experimental autoimmune neuritis as studied by high b-value q-space (1)H and (2)H DQF diffusion magnetic resonance spectroscopy. Magn Reson Med (2002) 0.88

Delayed diagnosis of cervical spondylotic myelopathy by primary care physicians. Neurosurg Focus (2013) 0.88

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One (2013) 0.88

Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Neurochem Int (2007) 0.87

Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases. Clin Rev Allergy Immunol (2012) 0.87

Geoepidemiology of myasthenia gravis [corrected]. Autoimmun Rev (2009) 0.87

Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background. Neurobiol Aging (2009) 0.86

Quantitative detection of thrombin activity in an ischemic stroke model. J Mol Neurosci (2013) 0.86

Participation of family members in ward rounds: Attitude of medical staff, patients and relatives. Patient Educ Couns (2006) 0.86

Thrombin regulation of synaptic plasticity: implications for physiology and pathology. Exp Neurol (2013) 0.86

Antiinflammatory and immunomodulatory properties of statins. Immunol Res (2002) 0.86

Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes. Isr Med Assoc J (2010) 0.85

Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis (2008) 0.85

The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. Arthritis Rheum (2002) 0.85

Minimally invasive approach to far lateral lumbar disc herniation: technique and clinical results. Acta Neurochir (Wien) (2009) 0.85

Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression). J Autoimmun (2008) 0.85

Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus. Ann N Y Acad Sci (2010) 0.84

Pregnancy issues in scleroderma. Autoimmun Rev (2011) 0.84

Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors. Neurosurgery (2004) 0.84

Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Clin Neuropharmacol (2006) 0.84

Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? J Neural Transm (Vienna) (2010) 0.84

Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism. Clin Rheumatol (2006) 0.84

Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity (2007) 0.83

Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction. Mol Pharmacol (2003) 0.83

Immunology, autoimmunity, and autoantibodies in Parkinson's disease. Clin Rev Allergy Immunol (2012) 0.83

Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res (2005) 0.83

Thrombin regulation of synaptic transmission: implications for seizure onset. Neurobiol Dis (2012) 0.83

The EEG in E200K familial CJD: relation to MRI patterns. J Neurol (2011) 0.83

Thoracic and lung involvement in familial Mediterranean fever (FMF). Clin Chest Med (2002) 0.83

The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally. Clin Rev Allergy Immunol (2012) 0.82

The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism. Hippocampus (2014) 0.82

Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol (2008) 0.82

Graves' disease presenting as right heart failure. Isr Med Assoc J (2006) 0.82